ISRCTN14530045已完成未知
COPD Pal Phase 2: Assessing the uptake, engagement, and safety of a self-management app for Chronic Obstructive Pulmonary Disease. A pilot expediency study in a real-world setting
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 25
研究概览
简要总结
2021 Results article in https://doi.org/10.1007/s12553-021-00534-w (added 11/11/2021)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Willing and able to sign informed consent
- •2. Clinical diagnosis of COPD as defined by GOLD, i.e. greater than 40 years old, =10 pack years smoking history, post-bronchodilator FEV1/FVC ratio of 0.7, with FEV1 less than 80% predicted
- •3. Life expectancy greater than 6 months
排除标准
- •1. Cognitive, visual, or motor impairment that would affect ability to see or use a smart phone
- •2. Current hospital inpatient or nursing home resident
研究者
相似试验
已完成
不适用
Second Follow-up Study of COPD Patients and Healthy Controls for Evaluation of Predictive Non-coding RNA BiomarkersChronic Obstructive Pulmonary DiseaseNCT04895124Fraunhofer-Institute of Toxicology and Experimental Medicine63
已完成
不适用
COPD Pal Phase 1: A Self-management App in COPDCOPDNCT04142957Hywel Dda Health Board12
已完成
2 期
Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPDPulmonary Disease, Chronic ObstructiveNCT04882124Novartis Pharmaceuticals38
已完成
不适用
COPD Assessment in PracticeCOPDJPRN-UMIN000012592Third department of Internal Medicine, Wakayama Medical University1,400
已完成
2 期
Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease, COPDNCT03064113Mylan Inc.32